Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Halilbasic Emina |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Trauner, M; Fickert, P; Trivedi, P; Denk, G; Färkkilä, M; Dill, M; Villadsen, GE; Berg, C; Jorgensen, KK; Vetter, M; Müller, T; Müllhaupt, B; Schramm, C; Strassburg, C; Bantel, H; Böttler, T; Beuers, U; Louvet, A; Halilbasic, E; Stiess, M; Proels, M; Manns, MP Norucholic acid for the treatment of primary sclerosing cholangitis: baseline data from a phase III trial
J HEPATOL. Abstracts. 2023; 78(S1):S403-S403.-EASL Congress 2023; JUN 21-24, 2023; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Menz, M; Hinterleitner, L; Konigshofer, P; Halilbasic, E; Kunczer, V; Stojakovic, T; Reiberger, T; Fuchs, C; Trauner, M Glucagon like peptide-2 treatment improves liver and bile duct injury in the Mdr2-/- mouse model of sclerosing cholangitis
J HEPATOL. 2019; 70: E167-E168. Doi: 10.1016/S0618-8278(19)30301-9 [Poster]
Web of Science FullText FullText_MUG

 

Zhu, C; Boucheron, N; Muller, A; Majek, P; Fuchs, C; Baazim, H; Lercher, A; Halilbasic, E; Gulich, A; Sakaguchi, S; Sandner, L; Stojakovic, T; Scharnagl, H; Bergthaler, A; Ellmeier, W; Trauner, M 24-nor-ursodeoxycholic acid ameliorates inflammation by reshaping mTOR proteome and immunometabolism sensing programs in CD8 T cells
EUR J IMMUNOL. 2019; 49: 1282-1282.-17th International Congress of Immunology (IUIS); OCT 19-23, 2019; Beijing, PEOPLES R CHINA. [Poster]
Web of Science

 

Zhu, C; Boucheron, N; Muller, A; Majek, P; Fuchs, CD; Baazim, H; Halilbasic, E; Stojakovic, T; Bergthaler, A; Ellmeier, W; Trauner, M 24-nor-ursodeoxycholic acid ameliorates inflammation by reshaping mTOR proteome and immunometabolism sensing programs in CD8 T-cells
J HEPATOL. 2019; 70(1): E9-E10. Doi: 10.1016/S0618-8278(19)30016-7 [Poster]
Web of Science FullText FullText_MUG

 

Menz, M; Hinterleitner, L; Konigshofer, P; Halilbasic, E; Kunczer, V; Stojakovic, T; Reiberger, T; Fuchs, CD; Trauner, MH Glucagon like Peptide (GLP)-2 Treatment Improves Liver and Bile Duct Injury in the Mdr2-/- Mouse Model of Sclerosing Cholangitis
HEPATOLOGY. . 2018; 68: 831A-831A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 09-13, 2018; San Francisco, CA. [Poster]
Web of Science

 

Fuchs, CD; Paumgartner, G; Halilbasic, E; Leditznig, N; Wahlstrom, A; Stahlman, M; Stojakovic, T; Marschall, HU; Trauner, M Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(-/-) mice by modulating fecal bile acid composition and signaling
J HEPATOL. .. 2017; 66(1):S364-S364.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)31068-1 [Poster]
Web of Science FullText FullText_MUG

 

Traussnigg, S; Schattenberg, JM; Demir, M; Wiegand, J; Geier, A; Teuber, G; Hofmann, WP; Kremer, AE; Spreda, F; Kluwe, J; Petersen, J; Boettler, T; Halilbasic, E; Greinwald, R; Proels, M; Manns, MP; Fickert, P; Trauner, MH norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study
HEPATOLOGY. 2017; 66: 106A-107A.-68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; OCT 20-24, 2017; Washington, DC. [Oral Communication]
Web of Science

 

Trauner, M; Fickert, P; Hirschfield, G; Reiter, F; Altorjay, I; Marschall, U; Farkkila, M; Schramm, C; Spengler, U; Chapman, R; Bergquist, A; Schrumpf, E; Nevens, F; Halilbasic, E; Greinwald, R; Proels, M; Manns, MP; NORURSODEOXYCHOLIC ACID IMPROVES CHOLESTASIS IN PRIMARY SCLEROSING CHOLANGITIS: RESULTS OF A PHASE II DOSE FINDING STUDY.
J HEPATOL. 2016; 64: S208-S209.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(16)00171-9 [Oral Communication]
Web of Science FullText FullText_MUG

 

Trauner, MH; Fickert, P; Hirschfield, G; Denk, G; Altorjay, I; Marschall, HU; Farkkila, MA; Schramm, C; Spengler, U; Chapman, RW; Bergquist, A; Schrumpf, E; Nevens, F; Halilbasic, E; Greinwald, R; Prols, M; Manns, MP norUrsodeoxycholic acid (norUDCA) improves cholestasis in primary sclerosing cholangitis (PSC) independent of ursodeoxycholic acid (UDCA) pre-treatment and response
HEPATOLOGY. 2016; 63(1 SUPP):111A-111A.-67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 11-15, 2016; Boston, MA. [Oral Communication]
Web of Science

 

Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M ROLE OF FXR CONTROLLED Chop IN MEDIATING BILE ACID EFFECTS IN NAFLD.
J HEPATOL. 2015; 62(S2):S689-S689.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA. [Poster]
Web of Science

 

Kienbacher, C; Traussnigg, S; Halilbasic, E; Fuchs, C; Dolak, W; Steindl-Munda, P; Stojakovic, T; Fauler, G; Claudel, T; Trauner, M Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?
Z Gastroenterol. 2015; 53(5):501-501.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA. [Poster]

 

Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M Role of FXR controlled CHOP in mediating bile acid effects in NAFLD.
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M FXR CONTROLLED CHOP AS NOVEL KEY PLAYER IN NAFLD PROGRESSION.
J HEPATOL. 2014; 60(S1):S148-S148.-49th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 9-13, 2014; London, UNITED KINGDOM. [Poster]

 

Fuchs, CD; Claudel, T; Halilbasic, E; Stojakovic, T; Scharnagl, H; Österreicher, C; Hoesel, B; Paumgartner, G; Marschall, HU; Trauner, M ABCB11 (BSEP) knockout mice are proteced from methionine choline deficient diet induced steatohepatitis.
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Kienbacher, C; Traussnigg, S; Halilbasic, E; C; Fuchs, CD; Dolak, W; Steindl-Munda, P; Stojakovic, T; Fauler, G; Claudel, T; Trauner, M DISTURBED ENERGY METABOLISM AND LIPID PROFILE AFTER A 4 WEEK HIGH ORAL FRUCTOSE CHALLENGE: POSSIBLE ROLE OF BILE ACIDS.
J HEPATOL. 2014; 60(S1):S351-S351.-49th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 9-13, 2014; London, UNITED KINGDOM. [Poster]

 

Kienbacher, C; Traussnigg, S; Halilbasic, E; Fuchs, C; Dolak, W; Steindl-Munda, P; Stojakovic, T; Fauler, G; Gajdosik, M; Krebs, M; Claudel, T; Trattnig, S; Krssak, M; Trauner, M Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: Potential role of bile acids?
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M FXR controlled CHOP as novel key player in NAFLD progression.
HEPATOLOGY. 2013; 58(S1):542A-542A.-64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 1-5, 2013; Washington, DC, USA. [Poster]
Web of Science

 

Fuchs, CD; Claudel, T; Halilbasic, E; Stojakovic, T; Trauner, M INTRAHEPATIC CHANGES IN BILE ACID COMPOSITION PROTECTS BSEP (ABCB11) KO MICE FROM HEPATIC INFLAMMATION IN METHIONINE CHOLINE DEFICIENT DIET INDUCED NASH.
J HEPATOL. 2013; 58(S1):S32-S32.-48th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 24-28, 2013; Amsterdam, THE NETHERLANDS. Doi: 10.1016/S0168-8278(13)60072-0 [Oral Communication]
Web of Science FullText FullText_MUG

 

Fuchs, C; Claudel, T; Kumari, P; Stojakovic, T; Halilbasic, E; Spindelboeck, W; Gonzalez, F; Trauner, M FXR IS A KEY PLAYER IN NAFLD DEVELOPMENT BY CONTROLLING CHOP EXPRESSION.
J HEPATOL. 2012; 56(S2):S490-S490.-47th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(12)61248-3 [Poster]
Web of Science FullText FullText_MUG

 

Halilbasic, E; Claudel, T; Bachhofner, N; Kapusta, C; Fickert, P; Trauner, M Norursodeoxycholic Acid Counteracts Hepatic Acute Phase Response via Modulation of NF kappa B Signaling
HEPATOLOGY. 2012; 56: 539A-540A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
Web of Science

 

Fickert, P; Silbert, D; Moustafa, T; Halilbasic, E; Krones, E; Durchschein, F; Thueringer, A; Pollheimer, MJ; Zollner, G; Denk, H; Trauner, M DIFFERENTIAL EFFECTS OF NORUDCA AND UDCA IN OBSTRUCTIVE CHOLESTASIS IN MICE
HEPATOLOGY. 2011; 54: 775A-775A.-62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 04-08, 2011; San Francisco, CA. [Poster]
Web of Science

 

Fuchs, CD; Claudel, T; Kumari, P; Stojakovic, T; Haemmerle, G; Halilbasic, E; Gumhold, J; Silbert, D; Koefeler, H; Zechner, R; Trauner, M ATGL (PNPLA2) KNOCKOUT MICE ARE PROTECTED FROM HEPATIC ER-STRESS VIA OLEIC ACID ACCUMULATION.
J HEPATOL. 2011; 54: S41-S42.-46th Annual Meeting of the European Association for the Study of the Liver (EASL); MAR 30-APR 3, 2011; Berlin, GERMANY. Doi: 10.1016/S0168-8278(11)60095-0 [Poster]
Web of Science FullText FullText_MUG

 

Fuchs, CD; Moustafa, T; Haemmerle, G; Halilbasic, E; Gumhold, J; Silbert, D; Fickert, P; Zechner, R; Trauner, M ADIPOSE TRIGLYCERIDE LIPASE (ATGL) IS A NOVEL MODULATOR OF HEPATIC ER-STRESS
J HEPATOL. 2010; 52: S305-S305.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(10)60787-8 [Oral Communication]
Web of Science FullText FullText_MUG

 

Halilbasic, E; Claudel, T; Gumhold, J; Halsegger, S; Silbert, D; Fickert, P; Trauner, M PREGNANCY RESOLVES LIVER FIBROSIS AND IMPROVES SCLEROSING CHOLANGITIS IN MDR2 (ABCB4) -/- MICE VIA DIRECT ANTI-INFLAMMATORY EFFECTS OF SEX HORMONES
J HEPATOL. 2010; 52: S24-S24.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(10)60052-9 [Oral Communication]
Web of Science FullText FullText_MUG

 

Krones, E; Halilbasic, E; Grisold, A; Krause, R; Trauner, M; Fickert, P; Zollner, G Acute hepatitis species as a result of contamination of a food supplement with Cytotoxin-producing Bacillus species.
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A10-A11. [Poster]
Web of Science

 

Rainer, PP; Primessnig, U; Huber, MS; Sedej, SS; Halilbasic, E; Trauner, M; Yates, A; Pieske, B Pro-arrhythmic effects of increased primary bile-acid levels on human atrial myocardium
J f Kardiologie. 2010; -Annual Session of the Austrian Society for Cardiology; JUN 2-5; Salzburg, AUSTRIA. [Poster]

 

Fickert, P; Moustafa, T; Fuchsbichler, A; Claudel, T; Halilbasic, E; Zatloukal, K; Denk, H; Trauner, M Differential effects of nor UDCA and UDCA in the treatment of fatty liver and arteriosclerosis in western chow-fed ApoE knock out mice
J HEPATOL. 2008; 48: S42-S42.-Annual Meeting, EASL; April 2008; Milann, Italy. Doi: 10.1016/S0168-8278(08)60100-2 [Oral Communication]
Web of Science FullText FullText_MUG

 

Moustafa, T; Fickert, P; Silbert, D; Gumhold, J; Halilbasic, E; Trauner, MH LOSS OF FXR ATTENUATES SCLEROSING CHOLANGITIS AND BILIARY FIBROSIS IN MDR2(-/-) AND FXR(-/-) DOUBLE KNOCKOUT MICE
HEPATOLOGY. 2008; 48(4):777--59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; OCT 31-NOV 04, 2008; San Francisco, CA. [Poster]
Web of Science

 

Moustafa, T; Halilbasic, E; Fickert, P; Fuchsbichler, A; Gumhold, J; Silbert, D; Denk, H; Trauner, M Side chain modified bile acids modulate endoplasmic reticulum stress in Mdr2(-/-) mice in vivo and bile duct epithelial cells in vitro
J HEPATOL. 2008; 48: S54-S55.-EASL Annula Meeting; April 2008; Milan Italy. Doi: 10.1016/S0168-8278(08)60127-0 [Oral Communication]
Web of Science FullText FullText_MUG

 

Pfeifer, T; Buchebner, M;Kratzer, A;Chandak, PG;Patankar, J;Obrowsky, S;Rechberger, GN;Halibasic, E;Trauner, M;Vistoli, G;Kostner, GM;Kratky, D;Levak-Frank, S; Synthetic LXR agonist reduces atherosclerotic plaque by lowering cholesterol absorption and inhibiting cholesterol biosynthesis
Cellular Lipid Transport - Connecting Fundamental Membrane Assembly; OCT 22-26, 2008 ; Canmore, CANADA. 2008. [Poster]
FullText

 

Halilbasic, E; Fickert, P; Fuchbichler, A; Langner, C; Gumhold, J; Silbert, D; Maitra, U; Zatloukal, K; Denk, H; Trauner, M Taurine-conjugation critically determines the therapeutic effectiveness of 24-nor-ursodeoxycholic acid (norUDCA) in the treatment of sclerosing cholangitis in Mdr2 (ABCB4) knockout mice
J HEPATOL. 2007; 46: S51-S51.-EASL; April 11-15, 2007; Doi: 10.1016/S0168-8278(07)61714-0 [Oral Communication]
Web of Science FullText FullText_MUG

 

Wagner, M; Halilbasic, E; Fickert, P; Zollner, G; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Denk, H; Trauner, M Nuclear receptor (PXR, CAR) agonists induce adaptive hepatic transporter and enzyme expression in mouse liver
J HEPATOL. 2004; 40: 25-25.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90069-4
Web of Science FullText FullText_MUG

 

Wagner, M; Halilbasic, E; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Xenobiotic nuclear receptor (PXR, CAR) agonists coordinately stimulate a spectrum of detoxification enzymes and transport systems involved in the adaptive response to cholestasis in vivo.
HEPATOLOGY. 2004; 40: 489A-489A.-55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); OCT 29-NOV 02, 2004; Boston, MA.
Web of Science

 

Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Cholic acid (CA) and ursodeoxycholic acid (UDCA) exert different effects on hepatic and renal expression of Mrp4 and Mrp6, two novel ABC transporters
GASTROENTEROLOGY. 2004; 126: A16-A16.
Web of Science

 

Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Differential effects of ursodeoxycholic acid (UDCA) and cholic acid (CA) on hepatic and renal expression of MRP4 and MRP6, two novel abc transporters, in mice
J HEPATOL. 2004; 40: 25-25. Doi: 10.1016/S0168-8278(04)90070-0
Web of Science FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum